Healthcare transformation Avalere Health Advisory, with a focus on innovative solutions to complex healthcare problems, presents opportunities to upsell advisory and data-driven strategy services to pharma, payers, and health systems seeking integrated end-to-end support across product lifecycle and patient access initiatives.

Global expansion Recent launches and expansions, including new strategic offerings for Japanese biopharmaceuticals and a broader global footprint, indicate potential for cross-border consulting engagements, local market access studies, and regulatory/commercial strategy services in Asia-Pacific markets.

Genomics and CGP Avalere’s focus on comprehensive genomic profiling and precision cancer care creates sales opportunities for data analytics, payer policy navigation, and market access services around CGP adoption, reimbursement pathways, and patient access optimization.

Data and tech stack Utilizing tools like Snowflake, OpenAI, SPSS and Atlassian ecosystem suggests capacity to offer advanced analytics, AI-assisted insights, and streamlined collaboration for clients needing large-scale data integration, model development, and evidence generation.

Strategic partnerships Active involvement in industry events and collaborations with major pharma players signals opportunity to position Avalere as a preferred partner for coordinated pharma marketing models, claims analysis, and channel strategy across commercial teams.